Patients should monitor their thyroid health regularly
As with any therapeutic option, patients are educated on proper use, potential side effects, and realistic outcomes to support safe and informed care
Retatrutide and Fatty Liver: How 86% of Patients Cleared Liver Fat in Trials Completed Phase 2a study shows Retatrutide reduces liver fat by up to 82.4% in MASLD patients within 24 weeks
BPC-157 amplifies growth hormone activity not by increasing hormone levels but by upregulating the receptors that respond to it
(FDA Access Data) If you are struggling to eat enough, feel weak, have persistent reflux, or have a medical condition that affects nutrition needs, its best to check with your healthcare provider or a registered dietitian
these require baseline medical evaluation and ongoing provider monitoring